Dexamethasone and Farydak drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexamethasone (dexamethasone) and Farydak (panobinostat lactate). Common drug interactions include tremor among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Dexamethasone and Farydak. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

What is Farydak?

Farydak has active ingredients of panobinostat lactate. eHealthMe is studying from 1,513 Farydak users. Check the latest studies of Farydak.

On Jul, 31, 2026

87 people who take Dexamethasone and Farydak together, and have interactions are studied.

Dexamethasone and Farydak drug interactions.

What are the common drug interactions of Dexamethasone and Farydak, by gender? *:

female:

Tremor (trembling or shaking movements in one or more parts of your body)
Neuropathy peripheral (surface nerve damage)
Vomiting
General physical health deterioration (weak health status)
Dehydration (dryness resulting from the removal of water)
Hyperammonaemia
Nausea (feeling of having an urge to vomit)
Pneumonia
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Pyrexia (fever)
Malignant neoplasm progression (cancer tumour came back)
Bone pain
Chest pain
Hyperglycaemia (high blood sugar)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Constipation
Heart rate increased
Fatigue (feeling of tiredness)
Ascites (accumulation of fluid in the abdominal cavity)

What are the common drug interactions of Dexamethasone and Farydak, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Dysphagia (a condition in which swallowing is difficult or painful)
Hydrocephalus (water on the brain)
Hypertension (high blood pressure)
Muscular weakness (muscle weakness)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Respiratory distress (difficulty in breathing)

10-19:

Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Platelet count decreased

20-29:

n/a

30-39:

Headache (pain in head)

40-49:

n/a

50-59:

Anaemia (lack of blood)
Heart rate increased
Ascites (accumulation of fluid in the abdominal cavity)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Hepatic lesion
Hyperaemia (increase of blood flow to different tissues in the body)
Hypotension (abnormally low blood pressure)
Immunosuppression
Infusion related reaction
Lymphadenopathy (disease or enlargement of lymph nodes)

60+:

Diarrhoea
Malignant neoplasm progression (cancer tumour came back)
Vomiting
Death
Nausea (feeling of having an urge to vomit)
Hyperglycaemia (high blood sugar)
Blood lactate dehydrogenase increased
Tremor (trembling or shaking movements in one or more parts of your body)
Constipation
Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

Malignant Neoplasm Progression (cancer tumour came back): 10 people, 11.49%
Constipation: 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and Farydak?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously